Page last updated: 2024-10-27

fleroxacin and Infections, Chlamydia

fleroxacin has been researched along with Infections, Chlamydia in 4 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Research Excerpts

ExcerptRelevanceReference
"In a multicenter, randomized, open, comparative trial, patients with uncomplicated gonorrhea were treated with 400 mg of oral fleroxacin or 250 mg of intramuscular ceftriaxone."9.07Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea. ( Dalu, ZA; Douglas, JM; Handsfield, HH; Hook, EW; Jones, RB; McCormack, WM; Mogabgab, WJ; Shands, JW; Smith, BL; Viner, BL, 1993)
"In a multicenter, randomized, open, comparative trial, patients with uncomplicated gonorrhea were treated with 400 mg of oral fleroxacin or 250 mg of intramuscular ceftriaxone."5.07Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea. ( Dalu, ZA; Douglas, JM; Handsfield, HH; Hook, EW; Jones, RB; McCormack, WM; Mogabgab, WJ; Shands, JW; Smith, BL; Viner, BL, 1993)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, BL1
Mogabgab, WJ1
Dalu, ZA1
Jones, RB1
Douglas, JM1
Handsfield, HH1
Hook, EW1
Viner, BL1
Shands, JW1
McCormack, WM1
Ragnar Norrby, S1
Bowie, WR1
Willetts, V1
Megran, DW1
Pust, RA1
Ackenheil-Köppe, HR1
Weidner, W1
Meier-Ewert, H1

Trials

3 trials available for fleroxacin and Infections, Chlamydia

ArticleYear
Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea.
    The American journal of medicine, 1993, Mar-22, Volume: 94, Issue:3A

    Topics: Administration, Oral; Adolescent; Adult; Ceftriaxone; Chlamydia Infections; Chlamydia trachomatis; F

1993
Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Community-Acq

1997
Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Ciprofl

1989

Other Studies

1 other study available for fleroxacin and Infections, Chlamydia

ArticleYear
Clinical efficacy and tolerance of fleroxacin in patients with urethritis caused by Chlamydia trachomatis.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl D

    Topics: Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Drug Tolerance; F

1988